Bookmark

Add to MyYahoo RSS

Genentech News

News on Genentech (Ticker: RHHBY) continually updated from thousands of sources around the net.

Wednesday | Business Journal

Iconic Therapeutics snags $20 million, eyes challenge to Genentech

New Iconic Therapeutics CEO William Greene was involved in the early clinical development of Lucentis, an FDA-approved therapy for wet AMD, while at Genentech.

Comment?

Related Topix: Startups, Macular Degeneration, Health, Healthcare Law, Law, Venture Capital, Emerging Technology

Tue Apr 15, 2014

SFGate

Eye-disease drug is lucrative for Genentech, doctors

Some of the nation's most highly reimbursed doctors receive millions of dollars of Medicare payments a year from just one drug made by Genentech.

Comment?

Related Topix: Startups, Medicine, Ophthalmology, Macular Degeneration, Health, South San Francisco, CA

Wall Street Journal

Roche Sales Hurt by Strong Franc

Swiss drug maker Roche Holding AG reported a 1% dip in first-quarter revenue as the strong Swiss franc eroded the value of growing sales of its cancer drugs.

Comment?

Related Topix: Pegasys, Biotech, Startups, Roche Holding, Medicine, Roche Group, Five Prime Therapeutics, 454, Healthcare Industry

Mon Apr 14, 2014

IPKat

Another two bite the dust - Hospira v Genentech

The IPKat has just been perusing the meaty yet compact decision in the case of Hospira v Genentech ) which came out last Thursday from Mr Justice Birss.

Comment?

Related Topix: Startups, Herceptin, Trastuzumab (generic), Health, Breast Cancer, Healthcare Law, Law

Sat Apr 12, 2014

Business Journal

Thunder and wonder combine for a blast at Kentucky Science Center

The event is held in conjunction with the Kentucky Derby Festival's Thunder Over Louisville opening ceremonies since the Science Center has great views of the Ohio River where the fireworks and air show are held.

Comment?

Related Topix: Kentucky, Startups

Thu Apr 10, 2014

The Washington Post

Hospira Wins U.K. Court Challenge to Roche Cancer-Drug Patents

Hospira Inc.'s U.K. unit won a court ruling overturning two patents for Roche Holding AG's top- selling breast-cancer drug Herceptin, paving the way for the generic drug-maker to sell a cheaper competitor in the country.

Comment?

Related Topix: Hispanic Broadcasting, Television, Startups, Medicine, Health, Breast Cancer, Lake Forest, IL, Business News

Wed Apr 09, 2014

Hispanic Business

New Molecular Pharmaceuticals Findings from Genentech, Inc. Described

The Taconic Hepatic CYP Reductase Null mouse model possesses a targeted mutation that results in liver-specific deletion of the Por gene thereby resulting in a disruption of CYP metabolism in the liver."

Comment?

Related Topix: Startups

Bloomberg

Flu Drugs May Do More Harm Than Good, Researchers Find

Tamiflu and Relenza, antiviral drugs stockpiled by governments to tame influenza outbreaks, haven't been proven to prevent pandemics and may cause more harm in some patients than good, researchers said after reviewing 170,000 pages of clinical-trial data.

Comment?

Related Topix: Tamiflu, Oseltamivir (generic), Medicine, Relenza, Zanamivir (generic), Influenza, Health, Pegasys, Startups, Roche Holding

Mon Apr 07, 2014

Business Journal

More data, better drugs: Genentech, PatientsLikeMe ink groundbreaking research pact

Genentech Inc. will mine the deep online patient network of PatientsLikeMe to pinpoint ways of using patients' real experience with diseases and drugs for better research.

Comment?

Related Topix: PatientsLikeMe, Startups, Medicine, South San Francisco, CA

Bloomberg

Roche Will Work With Oryzon on Cancer-Suppressing Genes

Roche Holding AG will buy the rights to a drug meant to switch on genes that block cancer's growth in a deal to be announced today with Oryzon Genomics SA .

Comment?

Related Topix: Startups, Oncology, Medicine, Leukemia, Marlborough, MA

Thu Apr 03, 2014

ENR-Engineering News-Record

Webcor Signs On For FLEXLAB's First Private-Sector Project

Buildings do not always perform as expected, says Stephen E. Selkowitz, senior adviser for building science at the Lawrence Berkeley National Laboratory.

Comment?

Related Topix: Startups

Tue Apr 01, 2014

InvestorIdeas.com

Firestone Ventures (TSX.V:FV; FSE:F5V) Announces Management Changes

Firestone Ventures Inc. is pleased to announce the appointments of Mr. F. Carson Noel, LL.B., MBA, as President & CEO as well as Director of the Company, and Ms.

Comment?

Related Topix: Startups, South America, Ecuador, World News

Mon Mar 31, 2014

The Motley Fool

FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge

Now the Lexington, Mass.-based company will have to make something of it. Curis said today that the FDA has lifted the partial clinical hold on CUDC-427 , the experimental cancer drug it licensed from Genentech a few years ago.

Comment?

Related Topix: Healthcare Law, Law, Startups, South San Francisco, CA

Reuters

UPDATE 1-FDA allows Curis to resume testing cancer drug

Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing of its experimental cancer drug, lifting a November order halting enrolment in an early-stage trial.

Comment?

Related Topix: Biotech, Medicine, Curis, Healthcare Industry, Healthcare Law, Food and Drug Administration, Law, Health, Breast Cancer, Startups

Wed Mar 26, 2014

SFGate

Pressuring drugmakers for experimental therapies

Mikaela Knapp, of Folsom, smiles into the camera and vows to "keep up the fight."

Comment?

Related Topix: Startups, Facebook

Tue Mar 25, 2014

P&T Community

FDA Says - Yes' to Xolair (Omalizumab) for Patients With Chronic Hives

The FDA has approved Xolair for the treatment of chronic idiopathic urticaria , a form of chronic hives.

Comment?

Related Topix: Startups

Thu Mar 20, 2014

AndhraNews

Novartis introduces Lucentis in state of the art pre-filled syringe

Novartis International AG /Novartis introduces Lucentis in state of the art pre-filled syringe.

Comment?

Related Topix: Health, Macular Degeneration, Startups

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••